The ataxia-telangiectasia-mutated (ATM) protein kinase is rapidly and specifically activated in response to DNA double-strand breaks in eukaryotic cells. In this review, we summarize recent insights into the mechanism of ATM activation, focusing on the role of the Mre11/Rad50/Nbs1 (MRN) complex in this process. We also compare observations of the ATM activation process in different biological systems and highlight potential candidates for cellular factors that may participate in regulating ATM activity in human cells.
The ataxia-telangiectasia-mutated (ATM) protein kinase is rapidly and specifically activated in response to DNA double-strand breaks in eukaryotic cells. In this review, we summarize recent insights into the mechanism of ATM activation, focusing on the role of the Mre11/Rad50/Nbs1 (MRN) complex in this process. We also compare observations of the ATM activation process in different biological systems and highlight potential candidates for cellular factors that may participate in regulating ATM activity in human cells. Oncogene (2007) 26, 7741-7748; doi:10.1038/sj.onc.1210872 Keywords: ATM; MRN; DNA repair; checkpoints Ataxia-telangiectasia mutated (ATM) is a serine-threonine kinase that is activated when cells are exposed to DNA double-strand breaks (DSBs) (Shiloh, 2006) . ATM phosphorylates a number of proteins involved in cell cycle checkpoint control, apoptotic responses and DNA repair, including p53, Chk2, BRCA1, RPAp34, H2AX, SMC1, FANCD2, Rad17, Artemis and Nbs1. Phosphorylation of these and other substrates by ATM initiates cell-cycle arrest at G 1 /S, intra-S and G 2 /M checkpoints and also promotes DNA repair. Mutations in the ATM gene are responsible for the rare autosomal recessive disorder ataxia-telangiectasia (A-T), characterized by cerebellar degeneration, immunodeficiency and an increased risk of cancer. Cells from individuals with A-T exhibit defects in DNA damage-induced checkpoint activation, radiation hypersensitivity and an increased frequency of chromosome breakage (Shiloh, 1997; Petrini, 2000) .
The role of the MRN complex in ATM activation
The Mre11/Rad50/Nbs1 (MRN) complex has been shown by several groups to be required for the ATM signaling pathway (Lim et al., 2000; Buscemi et al., 2001; Girard et al., 2002; Nakanishi et al., 2002; Yazdi et al., 2002; Uziel et al., 2003) . Most of these studies were performed using cells derived from patients with Nijmegen Breakage Syndrome (NBS) or Ataxia-TelangiectasiaLike-Disorder (ATLD), which are caused by hypomorphic alleles of the Nbs1 or Mre11 genes, respectively (Carney et al., 1998; Varon et al., 1998; Stewart et al., 1999) . The MRN complex was first considered to be in the same pathway with ATM because both NBS and ATLD patients exhibit similar clinical and cellular phenotypes compared to A-T patients, including chromosomal instability, radiation sensitivity and defects in cell cycle checkpoints. Girard et al. (2002) showed that phosphorylation of p53 on Ser15 was impaired in NBS cells following exposure to low doses of ionizing radiation (IR), suggesting that Nbs1 may be required for ATMdependent phosphorylation of substrates in cells. Uziel et al. (2003) also showed that ATM-dependent phosphorylation of p53, Chk2 and Mdm2 was defective in ATLD cells after treatment with neocarzinostatin (NCS), a radiomimetic agent. A recent study confirmed that Nbs1 is required for ATM autophosphorylation as well as the association of active ATM with chromatin after the induction of endonuclease-generated DSBs (Berkovich et al., 2007) . These findings suggest that a functional MRN complex is required for ATM activation after DNA damage.
The functional relationship between ATM and the MRN complex has also been demonstrated using virusinfected cells. By studying the ATM signaling pathway after infection with adenovirus, Weitzman and co-workers found that the MRN complex functions upstream of ATM in mammalian cells (Stracker et al., 2002) . They showed that the cellular DNA damage response through ATM and ATR is blocked by wildtype adenovirus, which relocalizes and degrades the MRN complex through the action of the viral proteins E1b55K/E4orf6 and E4orf3. As a result, ATM autophosphorylation and chromatin retention after treatment with NCS is abrogated (Carson et al., 2003; Araujo et al., 2005) . Their findings show that the MRN complex acts upstream of ATM during adenovirus infection and that the combined actions of the MRN complex and ATM in DNA repair and checkpoint control block virus replication and infection. In support of this, Wu et al. (2004) also showed that SV40 large T antigen can interact with Nbs1 and that this interaction disrupts Nbs1-mediated suppression of SV40 replication. Recently, infection of cells with herpes simplex virus (HSV) was also shown to induce an ATM-and MRN-dependent DNA-damage response, including ATM autophosphorylation and phosphorylation of ATM target substrates. Phosphorylation of Nbs1, p53 and Chk2 were not observed in A-T cells and were delayed in NBS cells, suggesting that a functional MRN complex is required for efficient ATM activation (Shirata et al., 2005) .
Significant insight into the mechanism of ATM activation was generated by Bakkenist and Kastan (2003) , which demonstrated that ATM exists as an inactive dimer under normal conditions and converts into active monomers after DNA damage. They also demonstrated that autophosphorylation of ATM on Ser1981 accompanied ATM activation and was required for monomerization.
In agreement with numerous studies of the MRN complex and ATM in mammalian cells, we found that ATM interacts with the MRN complex directly in vitro, using purified recombinant proteins. The MRN complex also stimulates the kinase activity of monomeric ATM toward p53 and Chk2 by 12 to 15-fold. The mechanism of this stimulation appeared to be primarily through an increase in substrate recruitment by ATM (Lee and Paull, 2004) . From these findings, we proposed that the MRN complex binds to ATM, inducing conformational changes that facilitate an increase in the affinity of ATM toward its substrates.
We subsequently purified dimeric ATM, which, in contrast to monomeric ATM was inactive even in the presence of the MRN complex. Purified dimeric ATM also required linear DNA as well as the MRN complex for activity and under these conditions ATM activity was stimulated 80 to 200-fold over ATM alone (Lee and Paull, 2005) . These results suggest that the MRN complex acts as a sensor for DNA breaks and is required for DSB-induced ATM signaling. We also showed that the unwinding of DNA ends by the MRN complex is essential for the ATM stimulation. This was based on our analysis of the Rad50 S1202R mutant, which is deficient in ATP-dependent DNA unwinding (Moncalian et al., 2004) as well as in adenylate kinase activity (Bhaskara et al., 2007) . In agreement with this finding, experiments using Xenopus egg extracts also showed that the wild-type MRN complex restores ATM kinase activity in Mre11-depleted Xenopus extracts but not the MR(S1202R)N-mutant complex (Costanzo et al., 2004) .
Functions of Nbs1 in the MRN complex
The Nbs1 protein is essential in mammals (Zhu et al., 2001) , as are Mre11 and Rad50 (Xiao and Weaver, 1997; Luo et al., 1999) . But cells from NBS patients can be used to analyse the importance of Nbs1 for ATM signaling since these cells do not have wild-type Nbs1 and the MRN complex they have is present at a significantly lower level compared to normal cells. Most NBS patients carry a deletion mutation, 657del5 and contain low levels of a 70-kDa N-terminally truncated form of Nbs1 (p70) made by internal translation initiation upstream of the deletion site (Maser et al., 2001) . Nbs1 (p70) forms a complex with Mre11 and Rad50 because it contains the Mre11 binding domain; however, this mutant does not contain the FHA or the BRCT protein-protein interaction domains present in the N-terminus of the wild-type protein. Although MRN (p70) is present at very low levels in NBS cells, this hypomorphic Nbs1 mutant has some residual functions of the MRN complex (Maser et al., 2001; Lee et al., 2003a; Lee and Paull, 2004) . In a mouse model of the human NBS disorder, B cells expressing low levels of p70 exhibit partial defects in ATM autophosphorylation and phosphorylation of some downstream targets (including SMC1 and Chk2), although p53 phosphorylation is normal after IR exposure (Difilippantonio et al., 2005) .
The Nbs1 protein plays many roles in the functions of the MRN complex, some of which are still being elucidated. It is required for nucleotide-dependent DNA binding by the complex and ATP-dependent DNA unwinding, suggesting that Nbs1 regulates MR catalytic functions (Lee et al., 2003a) . In NBS cells, which contain very low levels of the p70 form of Nbs1, Mre11 and Rad50 were shown to be distributed in the cytoplasm, suggesting that Nbs1 is required for nuclear localization of these proteins (Carney et al., 1998; Difilippantonio et al., 2005) . Mapping of the domains within the Nbs1 protein showed that a 101 amino-acid domain in the Nbs1 C-terminus interacts with a 319 amino-acid domain in the N-terminus of Mre11 (DesaiMehta et al., 2001) . Furthermore, the C-terminal half of Nbs1 is sufficient to localize in the nucleus with the MR complex, although these interactions were not sufficient to result in nuclear focus formation. These findings suggest that one of the primary functions of Nbs1 is to localize Mre11 and Rad50 in the nucleus. Cerosaletti et al. (2006) later showed that insertion of a nuclear localization signal on Mre11 resulted in nuclear localization of MR in the absence of Nbs1, but that the complex could not induce ATM autophosphorylation or phosphorylation of its downstream targets. We also found in vitro that the MR complex was unable to activate dimeric ATM (Lee and Paull, 2005) , even though phosphorylation of p53 by monomeric ATM was stimulated by MR in the absence of Nbs1 (Lee and Paull, 2004) . These results suggest that Nbs1 has a very specific role in activating dimeric ATM, in addition to recruiting MR to DSB sites.
Functions of the N-terminus of Nbs1
Nbs1 contains a forkhead-associated (FHA) domain (aa 24-108), a breast cancer C-terminal (BRCT) domain (aa 108-196) and a second putative BRCT domain (aa 221-330) in its N-terminus (Becker et al., 2006) (Figure 1 ). These domains have been shown to be essential for nuclear foci formation and also contribute to chromatin association and IR-induced responses of the MRN complex (Tauchi et al.,
2001
; Kobayashi et al., 2002; Zhao et al., 2002; Cerosaletti and Concannon, 2003) . Concannon and co-workers also showed that the expression of Nbs1 mutants containing point mutations in either the FHA or BRCT domains in NBS cells partially restored ATM kinase activity toward Chk2 and SMC1 after exposure to 10 Gy IR (Cerosaletti and Concannon, 2003) , suggesting that the N-terminus of Nbs1 contributes to but is not essential for ATM activation. A recent study from Nussenzweig and co-workers also showed that B cells from mice expressing p70 Nbs1 or Nbs1 containing H45A, a missense mutation in a critical residue in the FHA domain, exhibit mild defects in Chk2 and Chk1 phosphorylation, G2/M and S-phase checkpoint arrest and radiation sensitivity after IR (Difilippantonio et al., 2007) .
Using in vitro assays, we showed that the MRN(p70) complex, which lacks the N-terminus of Nbs1, exhibits normal MRN catalytic activities including DNA-binding and nuclease activity (Lee et al., 2003a) . However, this complex was only partially effective in stimulating Chk2 phosphorylation by ATM (Lee and Paull, 2004) . These results suggest that some characteristics exhibited by NBS cells may be due to the loss of both FHA and BRCT domains on Nbs1, in addition to the effects of the overall reduction in MRN complex levels.
Role of the C-terminus of Nbs1
The interaction domain of Nbs1 with ATM was initially suggested in Saccharomyces cerevisiae (Nakada et al., 2003) . Nakada and co-workers found that the C-terminus of Xrs2 (the budding yeast homolog of Nbs1) interacts with Tel1 (the budding yeast homolog of ATM) by twohybrid analysis and confirmed this by showing that a C-terminal 162 amino-acid deletion mutant of Xrs2 was not immunoprecipitated with Tel1. Studies with human MRN and ATM have shown that Nbs1 contains a phosphoinositide-3-kinase-related protein kinase (PIKK) interaction motif in its C-terminus that binds specifically to ATM (Falck et al., 2005) . Nbs1 lacking this C-terminal 20 amino-acid domain (DC) did not interact with ATM and did not form nuclear foci with phosphorylated ATM on Ser1981 after IR. Consistent with this finding, Russell and co-workers also showed that the FXFG motif (part of the proposed PIKK interaction domain) in the C-terminus of Nbs1 interacts with a specific region of HEAT repeats on ATM in fission yeast (You et al., 2005) . Russell also showed that the interaction between Mre11 and Nbs1 is required for ATM activation since the deletion of this domain abrogated ATM activation. Addition of a C-terminal fragment of Nbs1 that contains both Mre11-and ATM-binding domains could restore the ATM autophosphorylation in Nbs1-depleted Xenopus egg extracts, while a C-terminal Nbs1 fragment containing only the ATM-binding domain could not activate ATM (You et al., 2005) . This also suggests that Nbs1 has to form a complex with MR in order to activate ATM, a result consistent with our finding with purified components showing that Nbs1 by itself is incapable of stimulating ATM in vitro (Lee and Paull, 2005) .
Despite the importance of the Nbs1 PIKK interaction motif documented in human cells, Xenopus egg extracts and fission and budding yeast, mice expressing a C-terminal truncated Nbs1 mutant exhibit relatively subtle phenotypes (Difilippantonio et al., 2007; Stracker et al., 2007) . In mouse B cells expressing C-terminal truncated Nbs1, ATM interaction with Nbs1 and colocalization of ATM with g-H2AX was similar to normal cells (Difilippantonio et al., 2007) . In mice expressing this mutant Nbs1, there was a defect in DNA damage-induced intra-S checkpoint activation in mouse (Bakkenist and Kastan, 2003; Kozlov et al., 2006) . The identified domains within ATM consist of the nuclear localization signal (NLS) , the leucine zipper (LZ) (Savitsky et al., 1995b) , the FRAP/ATM/TRRAP (FAT) domain (Bosotti et al., 2000) , the Kinase domain (PI3-K) (Savitsky et al., 1995a) , and the FAT c-terminal (FATC) domain (Bosotti et al., 2000) . (b) Nbs1 is a 90 kDa protein, consisting of 754 amino acids. The phosphorylation sites (P) show the serine residues that are phosphorylated by ATM (Gatei et al., 2000; Lim et al., 2000; Stewart et al., 2001; Kim et al., 2002; Lee et al., 2003b) . The domains within Nbs1 include the forkhead-associated (FHA) domain (Featherstone and Jackson, 1998) , the breast cancer C-terminal (BRCT) domains (Becker et al., 2006) , the Mre11-binding domain (MBD) (Desai-Mehta et al., 2001 ) and the ATM-interacting domain (Falck et al., 2005) . embryonic fibroblasts (MEFs) and a defect in apoptosis in thymocytes (Stracker et al., 2007) . Disruption of the ATM binding domain in Nbs1 reduced ATM-dependent phosphorylation of Chk2 (Thr68), SMC1 (Ser966), Nbs1 (Ser343) and proapoptotic BID protein (Ser61 and Ser78) although p53 and H2AX phosphorylation was not influenced by this disruption (Falck et al., 2005; Difilippantonio et al., 2007; Stracker et al., 2007) . It is not yet clear why mouse cells appear to tolerate the loss of the C-terminus of Nbs1 while human cells show a much stronger dependence on this domain.
Although several studies have shown that ATM interacts with the C-terminus of Nbs1, we have found that ATM can associate with the MR complex even in the absence of Nbs1 (Lee and Paull, 2004) . This suggests that ATM makes multiple direct contacts with the MRN complex-one through Nbs1 and the other through MR. The C-terminal 20 amino acids of Nbs1 must therefore have an additional role in ATM activation in addition to recruiting ATM. This idea is consistent with the findings of Gautier and co-workers who have proposed a two-step mechanism for the activation of ATM (Dupre et al., 2006) . Their findings using Xenopus egg extracts suggest that MRN-dependent DNA tethering, in conjunction with ATM recruitment, first induces ATM monomerization through an increase in the local concentration of DNA. In their experiments, this first role of the MRN complex could be replaced by the addition of large amounts of linear DNA. In a second step, they show that monomeric ATM can be further activated by interacting with Nbs1. These results also suggest that direct interaction of Nbs1 is connected to ATM kinase activity. The mechanism of ATM activation through interaction with the C-terminus of Nbs1 is still unclear, but it is possible that the binding of this small domain to ATM causes conformational changes in ATM that facilitate activation.
Recent studies of ATM and Rad3-related kinase (ATR) activation by TopBP1 and Rad9 may also be informative since ATR is a related PIKK. ATR phosphorylation of Chk1 after hydroxyurea (HU) treatment was found to be stimulated by the interaction of ATR with the small active domain (AD) of TopBP1, which is recruited to chromatin through Rad9 phosphorylation (Delacroix et al., 2007; Lee et al., 2007) . They also showed that fusion of the TopBP1 AD with other chromatin-binding proteins including PCNA and H2B induces Chk1 phosphorylation after HU treatment. The PIKK-interaction domain on Nbs1 was originally shown by Jackson and co-workers to be analogous to a similar domain on ATR-interacting protein (ATRIP) that is important for the association with ATR (Falck et al., 2005) . ATRIP does not seem to function in the same manner as Nbs1, however, because ATRIP is constitutively bound to ATR and seems to primarily function in the recruitment of ATR to RPAbound DNA (Cortez et al., 2001 ).
Phosphorylation of Nbs1
Nbs1 is phosphorylated in an ATM-dependent manner after DNA damage on residues Ser278, Ser343 and Ser615 (Gatei et al., 2000; Lim et al., 2000; Stewart et al., 2001; Kim et al., 2002; Lee et al., 2003b) . Several studies showed that the expression of S343A mutant Nbs1 in NBS cells resulted in partial defects in IR-induced S-phase checkpoint activation, radiosensitivity and partial defects in ATM-dependent phosphorylation events including Chk2, SMC1 and FANCD2 (Lim et al., 2000; Buscemi et al., 2001; Nakanishi et al., 2002; Yazdi et al., 2002) . Our studies also showed that the MRN complex containing mutant Nbs1 (S343A) failed to stimulate the phosphorylation of Chk2 by ATM although p53 phosphorylation was normal in vitro. These results suggest that phosphorylation of Nbs1 is not absolutely required for ATM activation but may contribute to the recruitment of specific substrates by ATM.
ATM autophosphorylation
ATM autophosphorylation has been considered to be an indicator of its kinase activity since ATM was shown to be autophosphorylated on Ser1981 in vivo after treatment of IR or NCS (Bakkenist and Kastan, 2003) . As already mentioned, Bakkenist and Kastan (2003) showed that autophosphorylation of ATM after DNA damage is required for monomerization. Immunoprecipitated ATM was also shown to be autophosphorylated in vitro during incubation with g 32 -ATP, and the preincubation with ATP correlated with higher levels of kinase activity in vitro (Kozlov et al., 2003) . Later, other phosphorylation sites on ATM were found in addition to Ser1981, including Ser367 and Ser1893 (Kozlov et al., 2006) . Mutation of these autophosphorylation sites to alanine and expression in A-T cells resulted in defects in ATM-dependent phosphorylation and increased radiosensitivity. A recent study also confirmed that autophosphorylation is required for monomerization and chromatin association of ATM in human cells by immunoprecipitation and western blotting after co-transfection with Flag-and HA-ATM expression plasmids and induction of DSBs by the expression of the endonuclease IPpoI (Berkovich et al., 2007) . These results suggest that ATM autophosphorylation is important for monomerization and activation of ATM in vivo.
In contrast to the findings from human cells, studies in other organisms and in vitro have shown that autophosphorylation is dispensable for ATM monomerization and activation. Monomerization of ATM was observed in the absence of autophosphorylation in Mre11-depleted Xenopus egg extracts when high levels of linear DNA were used to circumvent the requirement for the MRN complex (Dupre et al., 2006) . These results suggest that ATM autophosphorylation is not required for ATM monomerization but that the MRN complex and DNA are required. Nussenzweig and co-workers also showed that expression of an S1987A (analogous to S1981A in humans) allele of ATM in the mouse yielded normal ATM-dependent phosphorylation of substrates after DNA damage and normal localization of ATM at DSB sites (Pellegrini et al., 2006) . It is still unclear why the function of ATM autophosphorylation appears to differ so dramatically between humans and mice. The originally identified autophosphorylation site, Ser1981, is not conserved in all ATM homologs (absent in Arabidopsis, Drosophila, budding yeast and fission yeast), also suggesting that ATM autophosphorylation, while important for regulation, may not be essential for the fundamental process of activation by DSBs.
In our in vitro system, we observed a very low level of autophosphorylation, which increased only threefold with the addition of DNA and the MRN complex. Under these conditions, we found that ATM-kinase activity increased 80-to 200-fold by the addition of both linear DNA and the MRN complex (Lee and Paull, 2005) . These findings suggest that ATM autophosphorylation does not correlate with kinase activity in our in vitro conditions. In addition, we also showed that the S1981A-dimeric ATM was fully activated and monomerized efficiently in vitro, similar to wild-type ATM. Therefore, using purified components in vitro, there appears to be no requirement for autophosphorylation (Lee and Paull, 2005) .
Considering the close relationship between ATM autophosphorylation and activation in human cells, however, it is likely that there are cellular factors that make ATM autophosphorylation essential in vivo. Several proteins have been shown to regulate ATM autophosphorylation and ATM-dependent phosphorylation events in human cells, thus one or more of these may affect ATM activity in a manner that depends on autophosphorylation. We envision that there could be two general and not necessarily mutually exclusive models to explain this: inhibitor vs activator hypotheses. An inhibitor may be present in human cells that actively prevents ATM activation in the absence of autophosphorylation. Conversely, autophosphorylation may mediate a direct interaction with an activator protein(s) that facilitates its activation in cells. The activator hypothesis seems less likely since the magnitude of activation we observed in vitro with purified components is similar to that observed in vivo; however, an autophosphorylation-dependent activation mechanism may occur in combination with inhibitory factor in human cells, which would give rise to a greater dependency on autophosphorylation in vivo.
Likely candidates for inactivators and activators of ATM
Recent articles show that two phosphatases, protein phosphatase 2A (PP2A) and protein phosphatase 5 (PP5), both affect ATM activity in vivo (Ali et al., 2004; Goodarzi et al., 2004) . PP2A is a member of the protein serine/threonine phosphatase family and is composed of a catalytic (C) subunit, a scaffolding A subunit and a regulatory B subunit. Guo et al. (2002) showed that the B55a regulatory subunit dissociates from the A and C subunits after DNA damage in ATM-dependent manner. A later study also showed that ATM interacts directly with the A subunit, and that the A and C subunits coimmunoprecipitate with ATM in unirradiated human cells but dissociate after IR exposure (Goodarzi et al., 2004) . They also showed that overexpression of a dominant-negative form of the C subunit-induced autophosphorylation of ATM on Ser-1981 in the absence of IR. This suggests that autophosphorylation of ATM is regulated by PP2A and that PP2A may constitutively dephosphorylate ATM in human cells. Recently, McConnell et al. (2007) identified a type 2A interacting protein (TIP), which interacts with the catalytic subunit of PP2A and inhibits PP2A phosphatase activity. They also showed that overexpression of TIP causes an increase in phosphorylation of ATM/ATR substrates, and depletion of TIP by siRNA causes a reduction in phosphorylation of ATM substrates. These data suggest that ATM activation is regulated by PP2A, although the mechanism of this regulation and the consequences of the ATMdependent subunit reorganization are not understood.
PP5 is also a member of the serine/threonine phosphatase family. Ali et al. (2004) showed that PP5 coimmunoprecipitates with ATM from human cells, but unlike PP2A, this interaction increases after exposure to either NCS or IR. Disruption of PP5 activity by siRNA resulted in defects in ATM activation and radioresistant DNA synthesis. In addition, the phosphatase activity of PP5 was shown to be required for ATM autophosphorylation and activation (Ali et al., 2004) . These findings suggest that PP5 might control ATM kinase activity by dephosphorylating ATM, the MRN complex, or other factors involved in ATM activation. One possibility is that ATM is phosphorylated on nonautophosphorylation sites in untreated cells and is then dephosphorylated by PP5 after DNA damage. An alternate possibility is that PP5 could act in conjunction with another yet to be identified protein factor to activate ATM by dephosphorylating this factor. The A subunit of PP2A has been shown to interact with PP5, suggesting that PP5 may require the A subunit of PP2A for its function (Lubert et al., 2001) . A third possibility is that PP5 may dephosphorylate PP2A, as a result activating ATM. Further experiments are required to determine which, if any, of these possibilities are correct.
Interestingly, another phosphatase, wild-type p53-induced phosphatase (Wip1), is recently reported to be a negative regulator of ATM. Wip1 is a member of the protein phosphatase 2C (PP2C) family and is a negative regulator of p38 mitogen-activated protein kinase (MAPK) (Takekawa et al., 2000) . Shreeram et al. (2006) showed that ATM autophosphorylation and phosphorylation of p53 was slightly increased in Wip1-null MEFs compared to wild-type MEFs, as well as in Wip1-siRNA-treated human cells after IR exposure. They also showed that overexpression of Wip1 in mouse cell or human cells reduced the levels of ATM autophosphorylation, and that phosphorylated Ser1981 on ATM is directly dephosphorylated by Wip1 (Shreeram et al., 2006) . These results suggest that Wip1 controls ATM kinase activity through its phosphatase activity.
One of the candidates for a coactivator of ATM is p53-binding protein 1 (53BP1), which colocalizes with g-H2AX at DNA DSBs (Schultz et al., 2000; Anderson et al., 2001; Rappold et al., 2001; Xia et al., 2001; Shang et al., 2003) . Disruption of 53BP1 by siRNA causes defects in intra-S-phase and G2-M checkpoint arrest after IR, decreases in ATM autophosphorylation and ATM substrate phosphorylation (Chk2 and SMC1) (DiTullio et al., 2002; Wang et al., 2002) . A separate study showed that these deficiencies in ATM-mediated signaling after treatment with siRNA specific to 53BP1 were more pronounced in NBS cells (Mochan et al., 2003) . This suggests that the role of 53BP1 is more critical in the absence of functional Nbs1 protein.
Although the mechanisms of ATM activation by 53BP1 are still unclear, recent studies of 53BP1 and its ortholog in fission yeast, Crb2, suggest that 53BP1 directly interacts with dimethylated Lys20 of Histone H4 (Botuyan et al., 2006) . These findings suggest that DNA damage could cause changes in chromatin structure in a manner that recruits 53BP1 to pre-existing dimethylated Lys20 of H4 analogous to the recruitment of Crb2 to H4-K20 methylated sites in fission yeast.
The BRCA1À/À human breast cancer line, HCC1937, exhibits defects in S-phase and G2/M checkpoint arrest similar to that of A-T cells after exposure to IR, thus BRCA1 is considered to be in the same pathway as ATM (Scully et al., 1999) . BRCA1 is also an ATM substrate and is phosphorylated on Ser1387, Ser1423 and Ser1524 after DNA damage (Cortez et al., 1999; Gatei et al., 2001) . Phosphorylation of BRCA1 on these sites is closely linked to S-phase and G2/M checkpoints (Xu et al., 2001 . Several studies also showed that BRCA1 is required for optimal levels of ATM-dependent phosphorylation of p53, c-Jun, Nbs1, Chk2, CtIP and SMC1, although the BRCA1 dependence of some of these phosphorylation events is controversial (Foray et al., 2003; Fabbro et al., 2004; Kitagawa et al., 2004) . Kitagawa et al. (2004) also showed that BRCA1 is required for focus formation by autophosphorylated ATM. These results suggest that BRCA1 is required for localization of already activated ATM at DNA DSBs and may mediate ATM-kinase activity toward several of its substrates.
Interestingly, Nbs1-independent ATM activation was reported recently through a novel factor, ATM interacting protein (ATMIN), when cells were treated with chloroquine under hypotonic conditions (Kanu and Behrens, 2007) . ATMIN was shown to interact with ATM through a C-terminal ATM interaction motif, which shows some similarity to the PIKK interaction motif in Nbs1. ATMIN colocalizes with autophosphorylated ATM after treatment of cells with chloroquine or in hypotonic conditions, but ATMIN dissociates from ATM after exposure to IR. ATM-dependent phosphorylation of p53 and Chk2 was reduced in ATMIN-depleted MEF cells after treatment with chloroquine and hypotonic conditions, suggesting that ATMIN regulates ATM activation in the absence of DNA breaks. These results are consistent with previous findings showing that chromatin-modifying agents induce autophosphorylation of ATM on Ser1981 in the absence of DNA breaks (Bakkenist and Kastan, 2003) .
Another potential ATM coactivator is p18 (AIMP3), which is a component of a translation complex and shows sequence homology to elongation factor subunit (EF-1) (Quevillon and Mirande, 1996 ), yet appears to function in the DNA damage response. Park et al. (2005) showed that p18 regulates ATM-dependent p53 induction after DNA damage, and that ATM and ATR directly interact with p18 after UV and/or adriamycin treatment. ATM autophosphorylation was increased by the overexpression of p18, and disruption of p18 using antisense RNA caused a reduction in p53 phosphorylation after adriamycin treatment. These findings suggest that p18 is required for efficient ATM autophosphorylation and activation, but the mechanism of this relationship is unknown.
Histone acetyltransferases are also possible cofactors for ATM autophosphorylation. Price and co-workers showed that ATM is acetylated by the Tip60 complex after DNA damage and that disruption of Tip60 by siRNA causes defects in ATM autophosphorylation, suggesting that the activity of Tip60 is required for ATM autophosphorylation (Sun et al., 2005 (Sun et al., , 2006 . They also showed that Tip60 is required for ATM-dependent phosphorylation of p53 and Chk2 in bleomycin-treated cells and interacts with the C-terminal FATC domain on ATM. Disruption of the interaction between ATM and Tip60 by mutations of the FATC domain in ATM caused defects in DNA damage-induced ATM signaling. These findings suggest that Tip60-mediated acetylation of ATM is required for autophosphorylation and activation.
hMOF, which is also a histone acetyltransferase, was also shown to have effects on ATM autophosphorylation and ATM activity similar to Tip60. Disruption of hMOF by siRNA or expression of dominant-negative forms of hMOF caused a decrease in ATM autophosphorylation and phosphorylation of Chk2 and p53 (Gupta et al., 2005) . Although both Tip60 and hMOF acetylate histones, which may alter chromatin structure and affect ATM indirectly, Tip60 is unique in its direct acetylation of ATM. Both histone and ATM acetylation are likely to play important roles in the regulation of ATM activity in vivo.
The mechanisms of ATM activation by these cofactors are still unclear. Since ATM has many substrates, these cofactors may be required for substrate-specific effects on ATM function. It is also possible that these are required for ATM activation by different stimuli. It will be interesting to find out if these cofactors work in the same pathway as the MRN complex or they are involved in MRN-independent pathways of ATM activation by different forms of cellular stress.
